Publications by authors named "P Deguiral"

Claim this Profile
E
Effect of 5 years of CT-scan and CEA follow-up on survival endpoints in patients with colorectal cancer: the PRODIGE-13 FFCD phase III trial.
C Lepage, J-M Phelip, L Cany, E Barbier, S Manfredi, P Deguiral

Ann Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postoperative circulating tumor DNA detection is associated with the risk of recurrence in patients resected for a stage II colorectal cancer.
Adrien Grancher, Ludivine Beaussire, Sylvain Manfredi, Karine Le Malicot, Marie Dutherage, Philippe Deguiral

Front Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of panitumumab in a cohort of patients with metastatic colorectal cancer in France: PANI OUEST, a post-EMA-approval descriptive study with a geriatric oncology focus.
Jean-Philippe Metges, Jean-Yves Douillard, Jean-François Ramée, Olivier Dupuis, Helene Senellart, Philippe Deguiral

Turk J Gastroenterol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long survival of patients with metastatic clear cell renal cell carcinoma. Results of real life study of 344 patients.
Eric Voog, Boris Campillo-Gimenez, Claude Elkouri, Franck Priou, Frederic Rolland, Philippe Deguiral

Int J Cancer· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study.
H Bourgeois, F Grudé, P Solal-Céligny, O Dupuis, E Voog, P Deguiral

Ann Oncol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis